Novelion Therapeutics Inc.
Profile
Mailing Address: c/o Norton Rose Fulbright Canada LLP
1800 - 510 West Georgia Street
Vancouver, British Columbia
V6B 0M3
Head Office Address: c/o Norton Rose Fulbright Canada LLP
1800 - 510 West Georgia Street
Vancouver, British Columbia
V6B 0M3
Contact Name: Glen Ibbott Principal Regulator: British Columbia
Business e-mail address: ir@qltinc.com Short Form Prospectus Issuer: Yes
Telephone Number: 604 707-7000 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland
Fax Number: 604 707-7179 Stock Exchange: NASDAQ
Date of Formation: Feb 3 1981 Stock Symbol: NVLN
Jurisdiction Where Formed: British Columbia Auditor: Deloitte & Touche
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 67001K Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $100,000,001 to $500,000,000


View This Company's Documents